Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |